Discontinuing hormonal gender reassignment: a nationwide register study (Q30107)
Jump to navigation
Jump to search
No description defined
- Discontinuing hormonal gender reassignment: a nationwide register study.
- Discontinuing hormonal gender reassignment
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discontinuing hormonal gender reassignment: a nationwide register study |
No description defined |
|
Statements
With increasing numbers of people seeking medical gender reassignment, the scientific community has become increasingly aware of the issue of detransitioning from social, hormonal or even surgical gender reassignment (GR). (English)
BACKGROUND (English)
© 2024. The Author(s). (English)
2024
This study aimed to assess the proportion of patients who discontinued their established hormonal gender transition and the risk factors for discontinuation. (English)
BACKGROUND (English)
© 2024. The Author(s). (English)
2024
A nationwide register-based follow-up was conducted. (English)
METHODS (English)
© 2024. The Author(s). (English)
2024
Data were analysed via cross-tabulations with chi-square statistics and t tests/ANOVAs. (English)
METHODS (English)
© 2024. The Author(s). (English)
2024
Multivariate analyses were performed via Cox regression, which accounts for differences in follow-up times. (English)
METHODS (English)
© 2024. The Author(s). (English)
2024
Of the 1,359 subjects who had undergone hormonal GR in Finland from 1996 to 2019, 7.9% discontinued their established hormonal treatment during an average follow-up of 8.5 years. (English)
RESULTS (English)
© 2024. The Author(s). (English)
2024
The risk for discontinuing hormonal GR was greater among later cohorts. (English)
RESULTS (English)
© 2024. The Author(s). (English)
2024
The hazard ratio was 2.7 (95% confidence interval 1.1-6.1) among those who had accessed gender identity services from 2013 to 2019 compared with those who had come to contact from 1996 to 2005. (English)
RESULTS (English)
© 2024. The Author(s). (English)
2024
Discontinuing also appeared to be emerging earlier among those who had entered the process in later years. (English)
RESULTS (English)
© 2024. The Author(s). (English)
2024
The risk of discontinuing established medical GR has increased alongside the increase in the number of patients seeking and proceeding to medical GR. (English)
CONCLUSIONS (English)
© 2024. The Author(s). (English)
2024
The threshold to initiate medical GR may have lowered, resulting in a greater risk of unbalanced treatment decisions. (English)
CONCLUSIONS (English)
© 2024. The Author(s). (English)
2024
Not applicable (the paper does not present a clinical trial). (English)
TRIAL REGISTRATION NUMBER (TRN) (English)
no value
© 2024. The Author(s). (English)
2024
Riittakerttu (English)
Kaltiala (English)
R
Mika (English)
Helminen (English)
M
Timo (English)
Holttinen (English)
T
Katinka (English)
Tuisku (English)
K
22 August 2024
19 August 2024